Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-363-5p regulates liver disease via the MAPK/ERK signaling pathway by targeting CPEB2 in chicken. | Poult Sci | 2025 | 40803288 | PubTator, text mining | PubMed |
| Polyphyllin H inhibits malignant progression of ovarian cancer in patient-derived xenograft mouse models by regulating CGN/RhoA/Rock2 axis: an experimental research. | Int J Surg | 2025 | 40773225 | PubTator, text mining | PubMed |
| Rational Design of 6-Amino-2-Piperazinylpyridine-Based ROCK2 Inhibitors With Anti-Breast Cancer Metastatic Efficiency. | Arch Pharm (Weinheim) | 2025 | 40772594 | PubTator, text mining | PubMed |
| Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer's Disease. | Curr Neuropharmacol | 2025 | 40754867 | PubTator, text mining | PubMed |
| AMF30a promotes survival and function of human corneal endothelial cells by regulating TGF-β/ROCK/HIPPO pathway. | Sci Rep | 2025 | 40753109 | PubTator, text mining | PubMed |
| Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury. | Eur J Pharmacol | 2025 | 40749867 | PubTator, text mining | PubMed |
| Keratinocyte-derived VEGF-A is an essential pro-migratory autocrine mediator, acting through the KDR/GEF-H1/RhoA pathway. | Front Cell Dev Biol | 2025 | 40746859 | PubTator, text mining | PubMed |
| Successful use of belumosudil in a patient with chronic ocular GVHD: A case report. | Transpl Immunol | 2025 | 40744299 | PubTator, text mining | PubMed |
| DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug Discovery. | J Chem Inf Model | 2025 | 40736165 | PubTator, text mining | PubMed |
Transcriptome Analysis of Triple-Negative HCC1937 and MDA-MB-231 Breast Cancer Cells Treated with Kalanchoe pinnata Revealed the Regulation of Migration and Invasion via the Downregulation of the Genes JAK2, ROCK1 and ROCK2. | ACS Omega | 2025 | 40727786 | PubTator, text mining | PubMed |
| Emerging highly pathogenic H5N1 influenza triggers fibrotic remodeling in human airway organoids. | Emerg Microbes Infect | 2025 | 40712003 | PubTator, text mining | PubMed |
| Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration. | ACS Omega | 2025 | 40657111 | PubTator, text mining | PubMed |
Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial. | CNS Drugs | 2025 | 40627117 | PubTator, text mining | PubMed |
| Targeting the ROCK2/UBA52/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in Cholangiocarcinoma. | Cell Death Dis | 2025 | 40615369 | PubTator, text mining | PubMed |
| Differential effects of traditional cigarette, electronic cigarette, and tobacco heating product on human vascular smooth muscle cell phenotypic switch: A comparative functional perspective. | Atherosclerosis | 2025 | 40614667 | PubTator, text mining | PubMed |
| Pharmacokinetics of Belumosudil and Its Metabolites in Individuals With Hepatic Impairment. | Clin Transl Sci | 2025 | 40614122 | PubTator, text mining | PubMed |
| Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA. | Biomedicines | 2025 | 40564003 | PubTator, text mining | PubMed |
| Prostaglandin E2 dependent migration of human brain endothelial cells is mediated through Rho-Kinase-II. | PLoS One | 2025 | 40549735 | PubTator, text mining | PubMed |
| TNIK Regulates Cytoskeletal Organization to Promote Focal Adhesion Turnover and Mitosis in Lung Adenocarcinoma. | Front Biosci (Landmark Ed) | 2025 | 40464520 | PubTator, text mining | PubMed |
| USP35 promotes hepatocellular carcinoma proliferation through GASC1-mediated ROCK2 upregulation. | Transl Oncol | 2025 | 40424935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=8